open access

Vol 25, No 2 (2018)
Original articles — Basic science and experimental cardiology
Published online: 2017-09-06
Get Citation

Inducible miR-145 expression by HIF-1a protects cardiomyocytes against apoptosis via regulating SGK1 in simulated myocardial infarction hypoxic microenvironment

Nianzi Sun, Fanyan Meng, Ning Xue, Guanghui Pang, Qingxin Wang, Hongliang Ma
DOI: 10.5603/CJ.a2017.0105
·
Pubmed: 28980287
·
Cardiol J 2018;25(2):268-278.

open access

Vol 25, No 2 (2018)
Original articles — Basic science and experimental cardiology
Published online: 2017-09-06

Abstract

 Background: Myocardial infarction (MI) is partly due to myocardial cell damage caused by hypoxia. MicroRNAs (miRNAs) have been proved to be closely related to the development and progression of many cardiovascular diseases. This study investigated the role of miR-145 in cardiomyocytes under hypoxic condition.

Methods: The quantitative real-time polymerase chain reaction (qRT-PCR) was performed to test miR-145 expression in H9c2 cells with hypoxia-inducible factor (HIF)-a abnormal expression under hypoxic condition. The 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyltetrazolium bromide (MTT), Tran­swell assay and flow cytometry were used to investigate the effects of miR-145 on cell viability, migration and apoptosis under normoxic or hypoxic condition, respectively. Meanwhile, reactive oxygen species (ROS) content in hypoxic H9c2 cells was analyzed. Western blotting was used to explore the potential mechanism of miR-145 protective effects on cardiomyocytes. Expression levels of miR-145 and SGK1 in rat MI model were also assessed.

Results: Results showed that miR-145 was upregulated in H9c2 and HL-1 cells under hypoxic condi­tion, which was promoted by HIF-1a. MiR-145 overexpression enhanced cell viability and migration under normoxic condition. Under hypoxic condition, miR-145 overexpression promoted cell viability, inhibited apoptosis and ROS activity. Western blotting results proved that miR-145 overexpression inhibited the activation of apoptotic related factors, and promoted activation of PI3K/AKT signaling pathway via SGK1 upregulation. Expression levels of miR-145 and SGK1 were both upregulated in rat MI models.

Conclusions: HIF-1a could induce miR-145 upregulation in hypoxic H9c2 and HL-1 cells. MiR-145 protected H9c2 cells against hypoxic damage. SGK1 upregulation and activated PI3K/AKT may have participated in the protective effects of miR-145 on cardiomyocytes.

Abstract

 Background: Myocardial infarction (MI) is partly due to myocardial cell damage caused by hypoxia. MicroRNAs (miRNAs) have been proved to be closely related to the development and progression of many cardiovascular diseases. This study investigated the role of miR-145 in cardiomyocytes under hypoxic condition.

Methods: The quantitative real-time polymerase chain reaction (qRT-PCR) was performed to test miR-145 expression in H9c2 cells with hypoxia-inducible factor (HIF)-a abnormal expression under hypoxic condition. The 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyltetrazolium bromide (MTT), Tran­swell assay and flow cytometry were used to investigate the effects of miR-145 on cell viability, migration and apoptosis under normoxic or hypoxic condition, respectively. Meanwhile, reactive oxygen species (ROS) content in hypoxic H9c2 cells was analyzed. Western blotting was used to explore the potential mechanism of miR-145 protective effects on cardiomyocytes. Expression levels of miR-145 and SGK1 in rat MI model were also assessed.

Results: Results showed that miR-145 was upregulated in H9c2 and HL-1 cells under hypoxic condi­tion, which was promoted by HIF-1a. MiR-145 overexpression enhanced cell viability and migration under normoxic condition. Under hypoxic condition, miR-145 overexpression promoted cell viability, inhibited apoptosis and ROS activity. Western blotting results proved that miR-145 overexpression inhibited the activation of apoptotic related factors, and promoted activation of PI3K/AKT signaling pathway via SGK1 upregulation. Expression levels of miR-145 and SGK1 were both upregulated in rat MI models.

Conclusions: HIF-1a could induce miR-145 upregulation in hypoxic H9c2 and HL-1 cells. MiR-145 protected H9c2 cells against hypoxic damage. SGK1 upregulation and activated PI3K/AKT may have participated in the protective effects of miR-145 on cardiomyocytes.

Get Citation

Keywords

miR-145, myocardial infarction, hypoxia, HIF-1a, SGK1, PI3K/AKT

About this article
Title

Inducible miR-145 expression by HIF-1a protects cardiomyocytes against apoptosis via regulating SGK1 in simulated myocardial infarction hypoxic microenvironment

Journal

Cardiology Journal

Issue

Vol 25, No 2 (2018)

Pages

268-278

Published online

2017-09-06

DOI

10.5603/CJ.a2017.0105

Pubmed

28980287

Bibliographic record

Cardiol J 2018;25(2):268-278.

Keywords

miR-145
myocardial infarction
hypoxia
HIF-1a
SGK1
PI3K/AKT

Authors

Nianzi Sun
Fanyan Meng
Ning Xue
Guanghui Pang
Qingxin Wang
Hongliang Ma

References (36)
  1. Lloyd-Jones DA, Carnethon R, Simone M, et al. Heart Disease and Stroke Statistics—2008 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007; 115(5): e25–e146.
  2. Starčević JN, Petrovič D. Carotid intima media-thickness and genes involved in lipid metabolism in diabetic patients using statins--a pathway toward personalized medicine. Cardiovasc Hematol Agents Med Chem. 2013; 11(1): 3–8.
  3. Kariz S, Milutinović A, Bregar D, et al. The interleukin-1 receptor antagonist gene and the inhibitor of kappa B-like protein gene polymorphisms are not associated with myocardial infarction in Slovene population with type 2 diabetes. Coll Antropol. 2007; 31(2): 503–507.
  4. Reynolds LM, Wan Ma, Ding J, et al. DNA Methylation of the Aryl Hydrocarbon Receptor Repressor Associations With Cigarette Smoking and Subclinical Atherosclerosis. Circ Cardiovasc Genet. 2015; 8(5): 707–716.
  5. Tibaut M, Petrovič D. Oxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus. Cardiovasc Hematol Agents Med Chem. 2016; 14(1): 23–38.
  6. Roy S, Khanna S, Hussain SRA, et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 2009; 82(1): 21–29.
  7. Seyhan AA. microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges. Mol Biosyst. 2015; 11(5): 1217–1234.
  8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2): 281–297.
  9. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008; 110(1): 13–21.
  10. Ferracin M, Negrini M. Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn. 2015; 15(10): 1369–1381.
  11. McCormick R, Buffa FM, Ragoussis J, et al. The role of hypoxia regulated microRNAs in cancer. Curr Top Microbiol Immunol. 2010; 345: 47–70.
  12. Huang X, Ding L, Bennewith KL, et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell. 2009; 35(6): 856–867.
  13. Bruning U, Cerone L, Neufeld Z, et al. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol Cell Biol. 2011; 31(19): 4087–4096.
  14. Crosby ME, Kulshreshtha R, Ivan M, et al. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res. 2009; 69(3): 1221–1229.
  15. Chan YC, Khanna S, Roy S, et al. miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J Biol Chem. 2011; 286(3): 2047–2056.
  16. Yuk Ch. Sashwati Roy, and Chandan K. Sen. Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. J Biol Chem. 2011; 286(3): 2047–2056.
  17. Zgheib C, Zouein FA, Kurdi M, et al. Chronic treatment of mice with leukemia inhibitory factor does not cause adverse cardiac remodeling but improves heart function. European Cytokine Network. 2012; 23(4): 191–197.
  18. Divakaran V, Mann DL. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res. 2008; 103(10): 1072–1083.
  19. Eulalio A, Mano M, Dal Ferro M, et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature. 2012; 492(7429): 376–381.
  20. Ru P, Steele R, Hsueh EC, et al. Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity. Genes Cancer. 2011; 2(7): 720–727.
  21. Jiang H, Xiao J, Kang Bo, et al. PI3K/SGK1/GSK3β signaling pathway is involved in inhibition of autophagy in neonatal rat cardiomyocytes exposed to hypoxia/reoxygenation by hydrogen sulfide. Exp Cell Res. 2016; 345(2): 134–140.
  22. Zhang Ni, Su Y, Xu L. Targeting PKCε by miR-143 regulates cell apoptosis in lung cancer. FEBS Lett. 2013; 587(22): 3661–3667.
  23. Onoue S, Igarashi N, Yamada S, et al. High-throughput reactive oxygen species (ROS) assay: an enabling technology for screening the phototoxic potential of pharmaceutical substances. J Pharm Biomed Anal. 2008; 46(1): 187–193.
  24. Doiz O, Benito R, Sbihi Y, et al. Western blot applied to the diagnosis and post-treatment monitoring of human hydatidosis. Diagn Microbiol Infect Dis. 2001; 41(3): 139–142.
  25. López-Hernández B, Ceña V, Posadas I. The endoplasmic reticulum stress and the HIF-1 signalling pathways are involved in the neuronal damage caused by chemical hypoxia. Br J Pharmacol. 2015; 172(11): 2838–2851.
  26. Deng L, Blanco FJ, Stevens H, et al. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension. Circ Res. 2015; 117(10): 870–883.
  27. Caruso P, MacLean MR, Khanin R, et al. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol. 2010; 30(4): 716–723.
  28. Kulshreshtha R, Ferracin M, Wojcik SE, et al. A microRNA signature of hypoxia. Mol Cell Biol. 2007; 27(5): 1859–1867.
  29. Shen G, Li X, Jia Yf, et al. Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin. 2013; 34(3): 336–341.
  30. Pugh C. Early expression of angiogenesis factors in acute myocardial. New Engl J Med. 2000; 342(9): 8.
  31. Pashaei E, Guzel E, Ozgurses ME, et al. A Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets. PLoS One. 2016; 11(9): e0161491.
  32. Matsushita R, Seki N, Yoshino H, et al. Pd38-04 dual tumor-suppressors (Mir-145-5p/mir-145-3p) inducing cancer cell apoptosis via direct targeting Uhrf1 in bladder cancer. J Urol. 2016; 195(4): e924–e925.
  33. Ostenfeld M, Bramsen J, Lamy P, et al. Abstract #1395: miR-145 expression is reduced in bladder cancer, induces caspase-dependent and -independent cell death, and targets a 22-gene signature that is upregulated in cancer tissue. Cancer Research. 2009: 69.
  34. Shakibaei M, John T, Seifarth C, et al. Resveratrol inhibits IL-1 beta-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann N Y Acad Sci. 2007; 1095: 554–563.
  35. Liu G, Honisch S, Liu G, et al. Inhibition of SGK1 enhances mAR-induced apoptosis in MCF-7 breast cancer cells. Cancer Biol Ther. 2015; 16(1): 52–59.
  36. Schmidt EM, Gu S, Anagnostopoulou V, et al. Serum- and glucocorticoid-dependent kinase-1-induced cell migration is dependent on vinculin and regulated by the membrane androgen receptor. FEBS J. 2012; 279(7): 1231–1242.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl